Sanara MedTech Inc (SMTI)
31.50
+0.32
(+1.03%)
USD |
NASDAQ |
May 02, 12:39
Sanara MedTech Enterprise Value: 273.16M for May 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 01, 2024 | 273.16M |
| April 30, 2024 | 278.85M |
| April 29, 2024 | 283.94M |
| April 26, 2024 | 283.25M |
| April 25, 2024 | 282.04M |
| April 24, 2024 | 284.54M |
| April 23, 2024 | 285.41M |
| April 22, 2024 | 287.99M |
| April 19, 2024 | 295.67M |
| April 18, 2024 | 297.56M |
| April 17, 2024 | 276.78M |
| April 16, 2024 | 277.21M |
| April 15, 2024 | 282.39M |
| April 12, 2024 | 293.34M |
| April 11, 2024 | 288.42M |
| April 10, 2024 | 288.94M |
| April 09, 2024 | 292.39M |
| April 08, 2024 | 297.48M |
| April 05, 2024 | 296.87M |
| April 04, 2024 | 299.12M |
| April 03, 2024 | 304.63M |
| April 02, 2024 | 307.91M |
| April 01, 2024 | 318.60M |
| March 28, 2024 | 323.35M |
| March 27, 2024 | 325.93M |
| Date | Value |
|---|---|
| March 26, 2024 | 321.19M |
| March 25, 2024 | 316.88M |
| March 22, 2024 | 326.88M |
| March 21, 2024 | 326.25M |
| March 20, 2024 | 325.99M |
| March 19, 2024 | 322.15M |
| March 18, 2024 | 315.07M |
| March 15, 2024 | 320.10M |
| March 14, 2024 | 314.64M |
| March 13, 2024 | 322.66M |
| March 12, 2024 | 318.82M |
| March 11, 2024 | 315.84M |
| March 08, 2024 | 316.01M |
| March 07, 2024 | 318.65M |
| March 06, 2024 | 318.31M |
| March 05, 2024 | 321.56M |
| March 04, 2024 | 332.82M |
| March 01, 2024 | 336.83M |
| February 29, 2024 | 328.98M |
| February 28, 2024 | 325.31M |
| February 27, 2024 | 332.82M |
| February 26, 2024 | 319.08M |
| February 23, 2024 | 328.38M |
| February 22, 2024 | 328.38M |
| February 21, 2024 | 324.80M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
19.13M
Minimum
May 10 2019
409.13M
Maximum
Apr 10 2023
202.29M
Average
213.35M
Median
Sep 23 2022
Enterprise Value Benchmarks
| AptarGroup Inc | 10.56B |
| Daxor Corp | 47.86M |
| Precision Optics Corp Inc | 35.73M |
| Warby Parker Inc | 1.199B |
| Perspective Therapeutics Inc | 990.24M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.2372M |
| Revenue (Quarterly) | 17.69M |
| Total Expenses (Quarterly) | 19.87M |
| EPS Diluted (Quarterly) | -0.03 |
| Gross Profit Margin (Quarterly) | 89.89% |
| Profit Margin (Quarterly) | -1.34% |
| Earnings Yield | -1.65% |
| Normalized Earnings Yield | -3.061 |